BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26990627)

  • 1. Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995-2014.
    Lesko CR; Moore RD; Tong W; Lau B
    AIDS; 2016 Jun; 30(9):1447-55. PubMed ID: 26990627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death after diagnosis of noncommunicable disease comorbid conditions, stratified by injection drug use.
    Lesko CR; Lau B; Chander G; Moore RD
    AIDS; 2019 Feb; 33(2):285-293. PubMed ID: 30325772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU.
    Lesko CR; Edwards JK; Moore RD; Lau B
    AIDS; 2016 Sep; 30(14):2227-34. PubMed ID: 27314178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.
    Althoff KN; Gebo KA; Moore RD; Boyd CM; Justice AC; Wong C; Lucas GM; Klein MB; Kitahata MM; Crane H; Silverberg MJ; Gill MJ; Mathews WC; Dubrow R; Horberg MA; Rabkin CS; Klein DB; Lo Re V; Sterling TR; Desir FA; Lichtenstein K; Willig J; Rachlis AR; Kirk GD; Anastos K; Palella FJ; Thorne JE; Eron J; Jacobson LP; Napravnik S; Achenbach C; Mayor AM; Patel P; Buchacz K; Jing Y; Gange SJ;
    Lancet HIV; 2019 Feb; 6(2):e93-e104. PubMed ID: 30683625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use.
    Calkins KL; Canan CE; Moore RD; Lesko CR; Lau B
    BMC Med Res Methodol; 2018 Mar; 18(1):27. PubMed ID: 29523081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between serum albumin and serious non-AIDS events among people living with HIV.
    Ronit A; Hatleberg CI; Ryom L; Bonnet F; El-Sadr W; Reiss P; Weber R; Pradier C; De Wit S; Law M; d'Arminio Monforte A; Lundgren J; Mocroft A; Phillips AN; Sabin CA;
    AIDS; 2018 Aug; 32(13):1837-1848. PubMed ID: 29847331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 years.
    Bickel M; Marben W; Betz C; Khaykin P; Stephan C; Gute P; Haberl A; Knecht G; Wolf T; Brodt HR; Geiger H; Herrmann E; Jung O
    HIV Med; 2013 Mar; 14(3):127-35. PubMed ID: 22994610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of History of Injection Drug Use with External Cause-Related Mortality Among Persons Linked to HIV Care in an Urban Clinic, 2001-2015.
    Singh K; Chander G; Lau B; Edwards JK; Moore RD; Lesko CR
    AIDS Behav; 2019 Dec; 23(12):3286-3293. PubMed ID: 30955176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis.
    Marks C; Borquez A; Jain S; Sun X; Strathdee SA; Garfein RS; Milloy MJ; DeBeck K; Cepeda JA; Werb D; Martin NK
    PLoS Med; 2019 Nov; 16(11):e1002973. PubMed ID: 31770373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex work and HIV incidence among people who inject drugs.
    Kerr T; Shannon K; Ti L; Strathdee S; Hayashi K; Nguyen P; Montaner J; Wood E
    AIDS; 2016 Feb; 30(4):627-34. PubMed ID: 26558725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services.
    Thakarar K; Rokas KE; Lucas FL; Powers S; Andrews E; DeMatteo C; Mooney D; Sorg MH; Valenti A; Cohen M
    PLoS One; 2019; 14(11):e0225460. PubMed ID: 31770395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study.
    Rasmussen LD; Engsig FN; Christensen H; Gerstoft J; Kronborg G; Pedersen C; Obel N
    AIDS; 2011 Aug; 25(13):1637-46. PubMed ID: 21646903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.
    Janjua NZ; Islam N; Kuo M; Yu A; Wong S; Butt ZA; Gilbert M; Buxton J; Chapinal N; Samji H; Chong M; Alvarez M; Wong J; Tyndall MW; Krajden M;
    Int J Drug Policy; 2018 May; 55():31-39. PubMed ID: 29482150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
    Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
    AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data.
    Des Jarlais DC; Feelemyer JP; Modi SN; Arasteh K; Mathers BM; Degenhardt L; Hagan H
    PLoS One; 2012; 7(3):e31227. PubMed ID: 22396729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mortality among HIV-infected injecting drug users without AIDS diagnosis: implications for HIV infection epidemic modellers?
    van Haastrecht HJ; van den Hoek AJ; Coutinho RA
    AIDS; 1994 Mar; 8(3):363-6. PubMed ID: 8031515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults.
    Althoff KN; McGinnis KA; Wyatt CM; Freiberg MS; Gilbert C; Oursler KK; Rimland D; Rodriguez-Barradas MC; Dubrow R; Park LS; Skanderson M; Shiels MS; Gange SJ; Gebo KA; Justice AC;
    Clin Infect Dis; 2015 Feb; 60(4):627-38. PubMed ID: 25362204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
    Ryom L; Lundgren JD; De Wit S; Kovari H; Reiss P; Law M; El-Sadr W; Monforte AD; Mocroft A; Smith C; Fontas E; Dabis F; Phillips A; Sabin C;
    AIDS; 2016 Jul; 30(11):1731-43. PubMed ID: 26752282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining non-AIDS mortality among people who inject drugs.
    Mathers BM; Degenhardt L
    AIDS; 2014 Nov; 28 Suppl 4(4):S435-44. PubMed ID: 25409098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/AIDS among men who have sex with men and inject drugs--United States, 1985-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jun; 49(21):465-70. PubMed ID: 10882293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.